Low high-density lipoprotein cholesterol predicts cardiovascular events after carotid stenting: A long-term survey

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 5, 2007, Pages 950-954

  Niessner, Alexander ^a   Hofmann, R ^b   Kypta, A ^b   Steinwender, C ^b   Kerschner, K ^b   Kammler, J ^b   Leisch, F ^b   Huber, K ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

Author keywords

Carotid artery; HDL cholesterol; Infammation; Lipids; Stenting

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TICLOPIDINE;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR EFFECT; CAROTID ARTERY OBSTRUCTION; CONFIDENCE INTERVAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STENT; STROKE; SURVIVAL;

AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHOLESTEROL, HDL; DATA COLLECTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; STENTS;

EID: 34247853513     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02451.x     Document Type: Article

References (24)

1. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-501.
2. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lievre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touze E, Giroud M, Hosseini H, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660-71.
3. Ringleb PA, Allenberg J, Bruckmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet 2006; 368: 1239-47.
4. Biasi GM, Froio A, Diethrich EB, Deleo G, Galimberti S, Mingazzini P, Nicolaides AN, Griffin M, Raithel D, Reid DB, Valsecchi MG. Carotid plaque echolucency increases the risk of stroke in carotid stenting: The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 2004; 110: 756-62.
5. Hobson RW II, Howard VJ, Roubin GS, Brott TG, Ferguson RD, Popma JJ, Graham DL, Howard G. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004; 40: 1106-11.
6. Kastrup A, Groschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: A systematic review of the literature. Stroke 2003; 34: 813-9.
7. Kastrup A, Groschel K, Schulz JB, Nagele T, Ernemann U. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting. Stroke 2005; 36: 787-91.
8. Kastrup A, Skalej M, Krapf H, Nagele T, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting versus carotid endarterectomy in a single academic center. Cerebrovasc Dis 2003; 15: 84-9.
9. Mathur A, Roubin GS, Iyer SS, Piamsonboon C, Liu MW, Gomez CR, Yadav JS, Chastain HD, Fox LM, Dean LS, Vitek JJ. Predictors of stroke complicating carotid artery stenting. Circulation 1998; 97: 1239-45.
10. Roubin GS, New G, Iyer SS, Vitek JJ, Al-Mubarak N, Liu MW, Yadav J, Gomez C, Kuntz RE. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: A 5-year prospective analysis. Circulation 2001; 103: 532-7.
11. Sztriha LK, Voros E, Sas K, Szentgyorgyi R, Pocsik A, Barzo P, Szikra P, Makai A, Szolics A, Elek P, Rudas L, Vecsei L. Favorable early outcome of carotid artery stenting without protection devices. Stroke 2004; 35: 2862-6.
12. Theiss W, Hermanek P, Mathias K, Ahmadi R, Heuser L, Hoffmann FJ, Kerner R, Leisch F, Sievert H, von Sommoggy S. Pro-CAS: A prospective registry of carotid angioplasty and stenting. Stroke 2004; 35: 2134-9.
13. Wholey MH, Al-Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003; 60: 259-66.
14. Zahn R, Mark B, Niedermaier N, Zeymer U, Limbourg P, Ischinger T, Haerten K, Hauptmann KE, Leitner ER, Kasper W, Tebbe U, Senges J. Embolic protection devices for carotid artery stenting: Better results than stenting without protection? Eur Heart J 2004; 25: 1550-8.
15. Hofmann R, Niessner A, Kypta A, Steinwender C, Kammler J, Kerschner K, Grund M, Leisch F, Huber K. Risk score for peri-interventional complications of carotid artery stenting. Stroke 2006; 37: 2557-61.
16. Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov 2005; 4: 193-205.
17. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
18. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, JR McNamara, Kashyap ML, Hershman JM, Wexler LF, Rubins HB. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: A randomized controlled trial. JAMA 2001; 285: 1585-91.
19. Whitney EJ, Krasuski RA, Personius BE, Michalek JE, Maranian AM, Kolasa MW, Monick E, Brown BG, Gotto Jr AM. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: Effects on progression of coronary heart disease and clinical events. Ann Intern Med 2005; 142: 95-104.
20. Andrawes WF, Bussy C, Belmin J. Prevention of cardiovascular events in elderly people. Drugs Aging 2005; 22: 859-76.
21. Sacco RL, Benson RT, Kargman DE, Boden-Albala B, Tuck C, Lin IF, Cheng JF, Paik MC, Shea S, Berglund L. High-density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study. JAMA 2001; 285: 2729-35.
22. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth Jr WT, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004; 63: 1868-75.
23. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005; 3: 1618-27.
24. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, Timmel E, Kickinger B, Minar C, Pones M, Lalouschek W, Rumpold H, Maurer G, Wagner O, Minar E. Inflammation and Carotid Artery - Risk for Atherosclerosis Study (ICARAS). Circulation 2005; 111: 2203-9.